Stocktoria
DAVITA INC. DVA
DAVITA INC. (DVA) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $13.6B at a 5.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-07 | TD Cowen | Buy (up) |
| 2026-08-07 | Truist Securities | Hold (main) |
| 2026-08-05 | Barclays | Equal-Weight (main) |
| 2026-07-14 | Truist Securities | Hold (main) |
| 2026-07-10 | UBS | Buy (main) |
| 2026-07-09 | Barclays | Equal-Weight (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.052 |
| Retained earnings / assets | -0.019 |
| EBIT / assets | 0.117 |
| Equity / liabilities | -0.04 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| DVA | DAVITA INC. | 6/9 | 1.03 | 18.7 | +6.5% |
| AGL | agilon health, inc. | 2/9 | -7.3 | — | -2.1% |
| PGNY | Progyny, Inc. | 5/9 | 7.14 | 38.2 | +10.4% |
| SHC | Sotera Health Co | 6/9 | — | 63.6 | +5.7% |
| VMD | VIEMED HEALTHCARE, INC. | 5/9 | 5.41 | 26.5 | +20.5% |
| CCEL | CRYO CELL INTERNATIONAL INC | 5/9 | -3.07 | — | -1.3% |
| NIVF | NewGenIvf Group Ltd | 3/9 | 3.84 | 0.6 | — |
About DAVITA INC.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
FAQ
Is DVA financially healthy?
DAVITA INC.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does DVA pay a dividend?
No, DAVITA INC. does not currently pay a dividend.
How profitable is DVA?
In FY2025, DAVITA INC. had a net margin of 5.5%.
Is DVA overvalued or undervalued?
DAVITA INC. trades at about 18.4× trailing earnings — above its 10-year norm (10-year range 11.1×–61.0×, median 15.2×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for DVA?
The average Wall-Street price target for DAVITA INC. is $218.43, about 20.3% above the recent price, from 7 analysts (consensus: buy).
Is DVA a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on DAVITA INC.: a Piotroski F-score of 6/9, an Altman Z″ in the distress zone, a P/E of about 18.7×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.